SE427839B - Analogiforfaranden for framstellning av n-aryl-n-(1-l-4-piperidinyl)-aryl-acetamider - Google Patents

Analogiforfaranden for framstellning av n-aryl-n-(1-l-4-piperidinyl)-aryl-acetamider

Info

Publication number
SE427839B
SE427839B SE7610501A SE7610501A SE427839B SE 427839 B SE427839 B SE 427839B SE 7610501 A SE7610501 A SE 7610501A SE 7610501 A SE7610501 A SE 7610501A SE 427839 B SE427839 B SE 427839B
Authority
SE
Sweden
Prior art keywords
aryl
acetamides
piperidinyl
preparation
analogy
Prior art date
Application number
SE7610501A
Other languages
English (en)
Swedish (sv)
Other versions
SE7610501L (sv
Inventor
S Sanczuk
H K Fr Hermans
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of SE7610501L publication Critical patent/SE7610501L/xx
Publication of SE427839B publication Critical patent/SE427839B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56Nitrogen atoms
    • C07D211/58Nitrogen atoms attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • C07D211/66Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4 having a hetero atom as the second substituent in position 4

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE7610501A 1975-09-23 1976-09-22 Analogiforfaranden for framstellning av n-aryl-n-(1-l-4-piperidinyl)-aryl-acetamider SE427839B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US61513175A 1975-09-23 1975-09-23
US71375676A 1976-08-12 1976-08-12

Publications (2)

Publication Number Publication Date
SE7610501L SE7610501L (sv) 1977-03-24
SE427839B true SE427839B (sv) 1983-05-09

Family

ID=27087421

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7610501A SE427839B (sv) 1975-09-23 1976-09-22 Analogiforfaranden for framstellning av n-aryl-n-(1-l-4-piperidinyl)-aryl-acetamider

Country Status (29)

Country Link
JP (1) JPS6016417B2 (el)
AT (1) AT363935B (el)
AU (1) AU510029B2 (el)
BG (1) BG27543A3 (el)
CA (1) CA1068271A (el)
CH (1) CH628623A5 (el)
CS (1) CS222663B2 (el)
DE (1) DE2642856A1 (el)
DK (1) DK150478C (el)
ES (1) ES451768A1 (el)
FI (1) FI61482C (el)
FR (1) FR2325377A1 (el)
GB (1) GB1539473A (el)
GR (1) GR58469B (el)
HU (1) HU172964B (el)
IE (1) IE43802B1 (el)
IL (1) IL50522A (el)
IT (1) IT1073893B (el)
LU (1) LU75837A1 (el)
NL (1) NL187267C (el)
NO (1) NO147672C (el)
NZ (1) NZ181972A (el)
PH (1) PH12497A (el)
PL (2) PL192578A1 (el)
PT (1) PT65631B (el)
RO (1) RO70079A (el)
SE (1) SE427839B (el)
SU (1) SU747424A3 (el)
YU (1) YU39973B (el)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA765684B (en) * 1975-09-23 1978-04-26 Janssen Pharmaceutica Nv Novel n-aryl-n-(1-l-4-piperidinyl)-arylacetamides
JPS62260786A (ja) * 1986-05-08 1987-11-13 株式会社ヘキトク 燻瓦の製造ラインにおける焼成工程後の表面仕上げ装置
JO2769B1 (en) 2005-10-26 2014-03-15 جانسين فارماسوتيكا ان. في Rapid decomposition of physiologically antagonistic agents of the 2-dopamine receptor
JO2642B1 (en) 2006-12-08 2012-06-17 جانسين فارماسوتيكا ان. في Dopamine 2 receptor antagonists are rapidly hydrolyzed
JO2849B1 (en) 2007-02-13 2015-03-15 جانسين فارماسوتيكا ان. في Dopamine 2 receptor antagonists are rapidly hydrolyzed
JP2010525013A (ja) * 2007-04-23 2010-07-22 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 高速解離性ドパミン2受容体アンタゴニストとしてのピリジン誘導体
JP5431305B2 (ja) 2007-04-23 2014-03-05 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 高速解離性ドパミン2受容体アンタゴニストとしての4−アルコキシピリダジン誘導体
AU2008240729B2 (en) 2007-04-23 2012-08-23 Janssen Pharmaceutica N.V. Thia(dia)zoles as fast dissociating dopamine 2 receptor antagonists
CA2729313C (en) 2008-07-03 2016-08-30 Janssen Pharmaceutica Nv Substituted 6-(1-piperazinyl)-pyridazines as 5-ht6 receptor antagonists
DK2307374T3 (en) 2008-07-31 2017-05-01 Janssen Pharmaceutica Nv PIPERAZIN-1-YLTRIFLUORMETHYL-SUBSTITUTED PYRIDINES AS QUICK DISSOCATING DOPAMIN-2 RECEPTOR ANTAGONISTS

Also Published As

Publication number Publication date
BG27543A3 (en) 1979-11-12
CA1068271A (en) 1979-12-18
LU75837A1 (el) 1977-05-04
NO147672C (no) 1983-05-25
YU233676A (en) 1983-01-21
NO763054L (no) 1977-03-24
FI61482C (fi) 1982-08-10
DE2642856C2 (el) 1990-06-21
DK427876A (da) 1977-03-24
AU510029B2 (en) 1980-06-05
SU747424A3 (ru) 1980-07-23
AU1787876A (en) 1978-03-23
YU39973B (en) 1985-06-30
FR2325377A1 (fr) 1977-04-22
DK150478B (da) 1987-03-09
NO147672B (no) 1983-02-14
JPS5239683A (en) 1977-03-28
RO70079A (ro) 1982-10-26
PT65631A (en) 1976-10-01
DE2642856A1 (de) 1977-03-24
IE43802B1 (en) 1981-06-03
PT65631B (en) 1978-07-05
SE7610501L (sv) 1977-03-24
NL7610513A (nl) 1977-03-25
AT363935B (de) 1981-09-10
NL187267B (nl) 1991-03-01
GB1539473A (en) 1979-01-31
DK150478C (da) 1987-10-05
CH628623A5 (en) 1982-03-15
ATA702976A (de) 1981-02-15
IE43802L (en) 1977-03-23
CS222663B2 (en) 1983-07-29
JPS6016417B2 (ja) 1985-04-25
PL192578A1 (pl) 1979-02-26
IT1073893B (it) 1985-04-17
FI762698A (el) 1977-03-24
IL50522A (en) 1979-09-30
IL50522A0 (en) 1976-11-30
GR58469B (en) 1977-10-14
PH12497A (en) 1979-04-05
PL117323B1 (en) 1981-07-31
ES451768A1 (es) 1978-05-01
NL187267C (nl) 1991-08-01
NZ181972A (en) 1978-07-28
FR2325377B1 (el) 1980-04-18
HU172964B (hu) 1979-01-28
FI61482B (fi) 1982-04-30

Similar Documents

Publication Publication Date Title
SE433208B (sv) Forfarande for framstellning av fenoletrar
SE422941B (sv) Analogiforfarande for framstellning av tetracykliska pyrido-bensazepinforeningar
SE7605139L (sv) Forfarande for framstellning av vattenupptagande cellulosaetrar
SE430336B (sv) Forbettrat forfarande for framstellning av amoxicillinfrihydrat
SE420314B (sv) Analogiforfarande for framstellning av indolizinderivat
SE421209B (sv) Analogiforfarande for framstellning av tienobensodiazepiner
SE427839B (sv) Analogiforfaranden for framstellning av n-aryl-n-(1-l-4-piperidinyl)-aryl-acetamider
NO143625C (no) Analogifremgangsmaate for fremstilling av 2-metoksy-benzamider
SE435510B (sv) Analogiforfarande for framstellning av 3-fluor-6-piperazinylmorfantridiner
NO146058C (no) Analogifremgangsmaate for fremstilling av substituerte benzamider
SE432763B (sv) Forfarande for framstellning av nya homoftalimider
SE7606116L (sv) Forfarande for framstellning av 3-fenoxidbensaldehyder
SE427841B (sv) Analogiforfarande for framstellning av tienamycinderivat
SE7604781L (sv) Forfarande for framstellning av diarylhydroxibutylaminer
SE435716B (sv) Forfarande for framstellning av nya penicilliner
SE419083B (sv) Analogiforfarande for framstellning av nikotinoylamino-triazinderivat
SE421793B (sv) Analogiforfarande for framstellning naftyridinsubstituerade pyrrolderivat
SE404186B (sv) Forfarande for framstellning av cyklopropanolderivat
SE423814B (sv) Forfarande for framstellning av dibensofenazin- eller acenaftokinoxalinderivat
NO143314C (no) Fremgangsmaate for fremstilling av akrylamid
SE427840B (sv) Analogiforfarande for framstellning av tienamycinderivat
SE7610637L (sv) Forfarande for framstellning av 2-alkylindaner
SE446726B (sv) Forfarande for framstellning av 16-metoxiprostaglandiner
SE423233B (sv) Analogiforfarande for framstellning av 1,2,3,4-tetrahydroisokinoliner
SE7605427L (sv) Forfarande for framstellning av klorcyan

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7610501-4

Effective date: 19910409

Format of ref document f/p: F